SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announces the results of the clinical study entitled ‘Phase I and II Studies of Intravenous Rexin-G as Monotherapy for Gemcitabine-resistant Metastatic Pancreas Cancer’ at the ASCO Annual Meeting on June 6, 2010. The presentation will be discussed by Dr. Howard W. Bruckner, Bruckner Oncology, New York, NY.
MIAMI, Fla. — Foreclosure Support, an online listings provider of foreclosed homes for sale, reported that foreclosures dropped 9 percent nationwide during the month of April, leading experts to speculate that the foreclosure homes market may finally have plateaued. In addition to the 9 percent drop since March, foreclosures fell 2 percent from April of […]
NEW YORK, N.Y. — Is it intolerable to be allowed to only preview lost files and limited to use a few features of the leading data recovery software offerings? Do you want to break out from those limitations and have a real tryout to get a fair idea whether the lost files can be recovered […]
SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announces the clinical results of the study entitled ‘A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol’ at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute […]
